Your browser doesn't support javascript.
loading
Targeting OXPHOS de novo purine synthesis as the nexus of FLT3 inhibitor-mediated synergistic antileukemic actions.
Zhang, Pu; Brinton, Lindsey T; Gharghabi, Mehdi; Sher, Steven; Williams, Katie; Cannon, Matthew; Walker, Janek S; Canfield, Daniel; Beaver, Larry; Cempre, Casey B; Phillips, Hannah; Chen, Xuyong; Yan, Pearlly; Lehman, Amy; Scherle, Peggy; Wang, Min; Vaddi, Kris; Baiocchi, Robert; Wang, Ruoning; Sampath, Deepa; Alinari, Lapo; Blachly, James S; Lapalombella, Rosa.
Afiliación
  • Zhang P; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Brinton LT; College of Pharmacy, The Ohio State University, Columbus, OH, USA.
  • Gharghabi M; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Sher S; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Williams K; Department of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
  • Cannon M; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Walker JS; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Canfield D; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Beaver L; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Cempre CB; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Phillips H; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Chen X; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Yan P; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Lehman A; Center for Childhood Cancer and Blood Diseases, Hematology/Oncology and BMT, Abigail Wexner Research Institute at Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA.
  • Scherle P; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Wang M; Center for Biostatistics, The Ohio State University, Columbus, OH, USA.
  • Vaddi K; Prelude Therapeutics, Wilmington, DE, USA.
  • Baiocchi R; Prelude Therapeutics, Wilmington, DE, USA.
  • Wang R; Prelude Therapeutics, Wilmington, DE, USA.
  • Sampath D; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Alinari L; Center for Childhood Cancer and Blood Diseases, Hematology/Oncology and BMT, Abigail Wexner Research Institute at Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA.
  • Blachly JS; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Lapalombella R; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Sci Adv ; 8(37): eabp9005, 2022 Sep 16.
Article en En | MEDLINE | ID: mdl-36112677
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Sci Adv Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Sci Adv Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos